Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

AMS:ALFEN - Euronext Amsterdam - NL0012817175 - Common Stock - Currency: EUR

12.83  -0.17 (-1.31%)

Fundamental Rating

4

ALFEN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Electrical Equipment industry. The financial health of ALFEN is average, but there are quite some concerns on its profitability. ALFEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALFEN had negative earnings in the past year.
ALFEN had a positive operating cash flow in the past year.
ALFEN had positive earnings in 4 of the past 5 years.
In the past 5 years ALFEN always reported a positive cash flow from operatings.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

ALFEN has a worse Return On Assets (-7.45%) than 68.33% of its industry peers.
ALFEN has a worse Return On Equity (-17.74%) than 68.33% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Gross Margin value of 31.09%, ALFEN perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
ALFEN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALFEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALFEN has about the same amout of shares outstanding than it did 1 year ago.
ALFEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALFEN has been reduced compared to a year ago.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.59 indicates that ALFEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ALFEN (2.59) is better than 76.67% of its industry peers.
The Debt to FCF ratio of ALFEN is 1.59, which is an excellent value as it means it would take ALFEN, only 1.59 years of fcf income to pay off all of its debts.
ALFEN's Debt to FCF ratio of 1.59 is amongst the best of the industry. ALFEN outperforms 91.67% of its industry peers.
ALFEN has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
ALFEN has a better Debt to Equity ratio (0.28) than 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Altman-Z 2.59
ROIC/WACCN/A
WACC7.07%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.68. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
ALFEN has a Current ratio of 1.68. This is comparable to the rest of the industry: ALFEN outperforms 53.33% of its industry peers.
ALFEN has a Quick Ratio of 1.68. This is a bad value and indicates that ALFEN is not financially healthy enough and could expect problems in meeting its short term obligations.
ALFEN has a Quick ratio (1.00) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALFEN have decreased strongly by -191.15% in the last year.
Looking at the last year, ALFEN shows a decrease in Revenue. The Revenue has decreased by -3.34% in the last year.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%

3.2 Future

ALFEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 109.79% yearly.
The Revenue is expected to grow by 14.47% on average over the next years. This is quite good.
EPS Next Y504.03%
EPS Next 2Y186.1%
EPS Next 3Y110.22%
EPS Next 5Y109.79%
Revenue Next Year4.99%
Revenue Next 2Y7.95%
Revenue Next 3Y9.27%
Revenue Next 5Y14.47%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFEN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 19.89, which indicates a rather expensive current valuation of ALFEN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALFEN is on the same level as its industry peers.
ALFEN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 19.89
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALFEN indicates a rather cheap valuation: ALFEN is cheaper than 86.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.93
EV/EBITDA N/A
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALFEN's earnings are expected to grow with 110.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y186.1%
EPS Next 3Y110.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALFEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALFEN N.V.

AMS:ALFEN (3/7/2025, 7:00:00 PM)

12.83

-0.17 (-1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-12 2025-05-12
Inst Owners48.06%
Inst Owner ChangeN/A
Ins Owners0.55%
Ins Owner ChangeN/A
Market Cap279.05M
Analysts50.59
Price Target15.9 (23.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.2%
PT rev (3m)-4.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.64%
EPS NY rev (3m)-21.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-8.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.89
P/S 0.57
P/FCF 8.93
P/OCF 5
P/B 1.83
P/tB 2.23
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)0.65
Fwd EY5.03%
FCF(TTM)1.44
FCFY11.2%
OCF(TTM)2.57
OCFY20%
SpS22.42
BVpS7
TBVpS5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.09%
FCFM 6.41%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 93.52%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1
Altman-Z 2.59
F-Score5
WACC7.07%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
EPS Next Y504.03%
EPS Next 2Y186.1%
EPS Next 3Y110.22%
EPS Next 5Y109.79%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%
Revenue Next Year4.99%
Revenue Next 2Y7.95%
Revenue Next 3Y9.27%
Revenue Next 5Y14.47%
EBIT growth 1Y-172.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1147.83%
EBIT Next 3Y151.82%
EBIT Next 5Y90.02%
FCF growth 1Y207.54%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y890.24%
OCF growth 3Y74.32%
OCF growth 5Y31.69%